Orexigen Therapeutics
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
3344 N Torrey Pines Ct Ste 200, La Jolla...Phone Number
(858) 875-8600Website
www.orexigen.comRevenue
$63.4 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Orexigen Therapeutics
Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products primarily in the United States, Europe, and South Korea. It offers Contrave for the treatment of obesity. The company also offers Contrave under the Mysimba brand name. Orexigen Therapeutics, Inc. was founded in 2002 and is headquartered in La Jolla,...Explore more
Orexigen Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Orexigen Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Orexigen Therapeutics has new funding data
Check if Orexigen Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Orexigen Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Orexigen Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at Orexigen Therapeutics
Orexigen Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Orexigen Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Orexigen Therapeutics recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Orexigen Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Orexigen Therapeutics
Compare insights from companies similar to Orexigen Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Orexigen Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Orexigen Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Orexigen Therapeutics.
Orexigen Therapeutics financials insights
Gather financial insights about Orexigen Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2003
Series A
$11M
2005
Series B
$35M
2006
Series C
$30M
2007
Stock Offering
$84M
2015
Private Equity
$60M
2017
Debt
$49.6M
Orexigen Therapeutics Tech Stack
A closer look at the technologies used by Orexigen Therapeutics
See more technologies
Most Recent Scoops
Mergers & Acquisitions (M&A)
Orexigen Therapeutics announced its parent company, Nalpropion Pharmaceuticals, has been acquired by Currax Pharmaceuticals LLC. The terms of the transaction have not been disclosed.
Mergers & Acquisitions
Left Company
Executive Move
Omar Rifi, Vice President, Global Alliances, has left the organization.
Executive Moves, Left Company
Left Company
Executive Move
Monica Forbes, Vice President & Chief Financial Officer, has left the organization.
Executive Moves, Left Company
Lateral Move
Executive Move
Kris Hanson, who previously served as Vice President & Assistant General Counsel, has been named Vice President, Legal & Compliance.
Executive Moves, Lateral Move, Personnel Moves
Mergers & Acquisitions (M&A)
Mergers & Acquisitions
Orexigen Therapeutics News & Media
Orexigen Therapeutics, Inc. Enters Agreement for Sale of Company
SAN DIEGO, April 23, 2018 /PRNewswire/ -- Orexigen Therapeutics, Inc. (NASDAQ: OREX), a biopharmaceutical company focused on the treatment of obesity, announced today that it has entered into an asset purchase agreement with Nalpropion Pharmaceuticals, Inc. to sell substantially all of the assets of the company, subject to court approval. Under the terms of the agreement, Orexigen will sell the world-wide rights to Contrave® (naltrexone HCl / bupropion HCl extended release) /Mysimba™ (naltrexonOrexigen Therapeutics, Inc. Enters Agreement for Sale of Company
SAN DIEGO, April 23, 2018 /PRNewswire/ -- Orexigen Therapeutics, Inc. (NASDAQ: OREX), a biopharmaceutical company focused on the treatment of obesity, announced today that it has entered into an asset purchase agreement with Nalpropion Pharmaceuticals, Inc. to sell substantially all of the assets of the company, subject to court approval. Under the terms of the agreement, Orexigen will sell the world-wide rights to Contrave® (naltrexone HCl / bupropion HCl extended release) /Mysimba™ (naltrexonOrexigen Therapeutics, Inc. Enters Agreement for Sale of Company
SAN DIEGO, April 23, 2018 /PRNewswire/ -- Orexigen Therapeutics, Inc. (NASDAQ: OREX), a biopharmaceutical company focused on the treatment of obesity, announced today that it has entered into an asset purchase agreement with Nalpropion Pharmaceuticals, Inc. to sell substantially all of...Orexigen Therapeutics, Inc. Plans For Near-term Sale Using Structured Process Through Chapter 11 Of U.S. Bankruptcy Code
Bidding Process and Auction Projected to Conclude in May 2018 SAN DIEGO, March 12, 2018 /PRNewswire/ -- Orexigen Therapeutics, Inc. (NASDAQ: OREX), a biopharmaceutical company focused on the treatment of obesity, announced today that it has elected to file a voluntary petition under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware. Orexigen also intends to file a motion seeking authorization to pursue an auction and sale process under
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Orexigen Therapeutics
Sign Up For FreeTo access detailed company insights
Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products primarily in the United States, Europe, and South Korea. It offers Contrave for the treatment of obesity. The company also offers Contrave under the Mysimba brand name. Orexigen Therapeutics, Inc. was founded in 2002 and is headquartered... Read More
